New drugs for lung cancer

A comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more.

Lung cancer treatment that kills cancer cells also can affect normal cells, causing unwanted side effects. New lung cancer drugs called

Spotlight on Small Cell Lung Cancer. Treatments for small cell lung cancer have remained virtually the same for decades. Now, experts say that hope is on the horizon. New Therapies for Metastatic Lung Cancer. Several targeted drugs were approved in 2024 to treat the most common type of lung cancer.

If given FDA approval, epalrestat could be fast-tracked as an anti-cancer drug for lung cancer patients. In general, developing new drugs for

However, Pfizer's lung cancer drug is showing promising results. New clinical trial results show that Lorbrena (lorlatinib) stops lung cancer from advancing in patients with ALK-positive non-small cell lung cancer (NSCLC), a type of lung cancer that occurs when the ALK gene mutates and causes abnormal lung cell growth.

Moreover, Pfizer's new cancer drugs acquired through its Seagen cancer as it launches late-stage trials in lung and breast cancers.

lung cancer, which researchers hope to use to aid the design of new, targeted lung cancer treatments. Since then, TRACERx has helped to

new drugs that target biomarkers in lung cancer. For example, targeting the HER2 biomarker in lung cancer is important, as is reimagining

Breast Skin Cancer Lung Cancer trials test new and more effective ways to prevent, diagnose, and treat cancer. Trials can involve testing new drugs